 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 1 | 1/1 | 返回列表 |
| 查看: 877 | 回復(fù): 0 | |||
[交流]
檢測心臟受損標(biāo)志物ELISA試劑盒，用于動(dòng)物心血管研究
|
|
檢測心臟受損標(biāo)志物ELISA試劑盒 心臟受損時(shí)就會(huì)釋放心臟生物標(biāo)志物到血液中，檢測生物標(biāo)志物的水平可指示心臟受損的程度。標(biāo)志物比如心肌肌鈣蛋白-I是專一用于檢測心臟受損的標(biāo)志物，而肌紅蛋白，脂肪酸結(jié)合蛋白和MLC-1升高也是骨骼肌受損的結(jié)果。在人體中，肌紅蛋白和脂肪酸結(jié)合蛋白是高于基線的第一個(gè)標(biāo)志物，心臟受損后2-4h增加就可以測定，9-12h達(dá)到高峰，24-36h又回到基線。心肌肌鈣蛋白-I在4-6h超過基線，12-24h達(dá)到高峰，6-10天仍然會(huì)升高。我們一般的經(jīng)驗(yàn)是動(dòng)物心臟標(biāo)志物在受損（1-2h）快速達(dá)到高峰，在1-2天又回到基線。 ELISA試劑盒相關(guān)產(chǎn)品： ELISA Kit(96-well kit) 范圍 (ng/ml) 中文名稱 產(chǎn)品編號(hào) Mouse Cardiac Tn-I (for serum) 0.156 – 10 小鼠心肌肌鈣蛋白-I ELISA試劑盒（用于血清） ADM0709A Mouse Cardiac Tn-I (for plasma) 0.156 – 10 小鼠心肌肌鈣蛋白-I ELISA試劑盒（用于血漿） ADM0710A Mouse Cardiac Tn-I, Ultra Sensitive (for serum or plasma)1 0.039 – 2.5 小鼠心肌肌鈣蛋白-I 超靈敏ELISA試劑盒（用于血漿或血清） ADM0711A Rat Cardiac Tn-I (for serum) 0.156 – 10 大鼠心肌肌鈣蛋白-I ELISA試劑盒（用于血清） ADM0712A Rat Cardiac Tn-I (for plasma) 0.156 – 10 大鼠心肌肌鈣蛋白-I ELISA試劑盒（用于血漿） ADM0713A Rat Cardiac Tn-I, Ultra Sensitive (for serum or plasma)1 0.039 – 2.5 大鼠心肌肌鈣蛋白-I 超靈敏ELISA試劑盒（用于血漿或血清） ADM0714A Dog Cardiac Tn-I (for serum) 0.156 – 10 狗心肌肌鈣蛋白-I ELISA試劑盒（用于血清） ADM0715A Dog Cardiac Tn-I, Ultra Sensitive (for serum or plasma)1 0.039 – 2.5 狗心肌肌鈣蛋白-I 超靈敏ELISA試劑盒（用于血漿或血清） ADM0716A Pig Cardiac Tn-I (for serum) 0.039 – 2.5 豬心肌肌鈣蛋白-I ELISA試劑盒（用于血清） ADM0717A Pig Cardiac Tn-I (for plasma) 0.039 – 2.5 豬心肌肌鈣蛋白-I ELISA試劑盒（用于血漿） ADM0718A Pig Cardiac Tn-I, Ultra Sensitive (for serum or plasma)1 0.0156 – 1.0 豬心肌肌鈣蛋白-I 超靈敏ELISA試劑盒（用于血清或血漿） ADM0719A Monkey Cardiac Tn-I (for serum) 0.156 – 10 猴心肌肌鈣蛋白-I ELISA試劑盒（用于血清） ADM0720A Monkey Cardiac Tn-I, Ultra Sensitive (for serum or plasma)1 0.039 – 2.5 猴心肌肌鈣蛋白-I 超靈敏ELISA試劑盒（用于血清或血漿） ADM0721A Rabbit Cardiac Tn-I (for serum) 0.156 – 10 兔心肌肌鈣蛋白-I ELISA試劑盒（用于血清） ADM0722A RabbitCardiac Tn-I, Ultra Sensitive (for serum or plasma)1 0.0195 – 1.25 兔心肌肌鈣蛋白-I超靈敏 ELISA試劑盒（用于血清） ADM0723A Guinea Pig Cardiac Tn-I (for serum) 0.2 – 12.5 豚鼠心肌肌鈣蛋白-I ELISA試劑盒（用于血清） ADM0724A ELISA Kit （96-well kit） 范圍(ng/ml) 中文名稱 產(chǎn)品編號(hào) Mouse Myoglobin (for serum, plasma, & urine) 3.9 – 250 小鼠肌紅蛋白ELISA試劑盒（用于血清，血漿和尿） ADM0726A Rat Myoglobin (for serum, plasma, & urine) 1.56 – 100 大鼠肌紅蛋白ELISA試劑盒（用于血清，血漿和尿） ADM0727A Rabbit Myoglobin (for serum, plasma, & urine) 2 – 125 兔肌紅蛋白ELISA試劑盒（用于血清，血漿和尿） ADM0728A Dog Myoglobin (for serum, plasma, & urine) 3.9 – 250 狗肌紅蛋白ELISA試劑盒（用于血清，血漿和尿） ADM0729A Pig Myoglobin (for serum, plasma, & urine) 0.5 – 31.25 豬肌紅蛋白ELISA試劑盒（用于血清，血漿和尿） ADM0730A Monkey Myoglobin (for serum, plasma, & urine) 2 – 125 猴肌紅蛋白ELISA試劑盒（用于血清，血漿和尿） ADM0731A Guinea Pig Myoglobin (for serum, plasma, & urine) 1.56 – 100 豚鼠肌紅蛋白ELISA試劑盒（用于血清，血漿和尿 ADM0732A ELISA Kit （96-well kit） 范圍 (ng/ml) 中文名稱 產(chǎn)品編號(hào) Mouse Cardiac FABP (for serum & urine) 0.31 – 20 小鼠心肌葉酸結(jié)合蛋白ELISA試劑盒（用于血清和尿） ADM0733A Rat Cardiac FABP (for serum & urine) 0.078 – 5 大鼠心肌葉酸結(jié)合蛋白ELISA試劑盒（用于血清和尿） ADM0734A Dog Cardiac FABP (for serum & urine) 0.31 – 20 狗心肌葉酸結(jié)合蛋白ELISA試劑盒（用于血清和尿） ADM0735A Pig Cardiac FABP (for serum & urine) 0.78 – 25 豬心肌葉酸結(jié)合蛋白ELISA試劑盒（用于血清和尿） ADM0736A Rabbit Cardiac FABP (for serum & urine) 1.56 – 100 兔心肌葉酸結(jié)合蛋白ELISA試劑盒（用于血清和尿） ADM0737A Monkey Cardiac FABP (for serum) 3.9 – 250 猴心肌葉酸結(jié)合蛋白ELISA試劑盒（用于血清和尿） ADM0738A ELISA Kit （96-well kit） 范圍 (ng/ml) 中文名稱 產(chǎn)品編號(hào) Rat & Mouse Cardiac MLC-1 (for serum) 0.078 – 2.5 大鼠&小鼠心肌肌球蛋白輕鏈-1ELISA試劑盒（用于血清） ADM0739A 使用我們的動(dòng)物肌鈣蛋白-I,肌紅蛋白，脂肪酸結(jié)合蛋白試劑盒結(jié)果見下圖。血漿取自于兔心臟局部缺血前，缺血中及再灌注后，下圖就體現(xiàn)出各自標(biāo)志物的水平。和人的臨床表現(xiàn)相同，肌紅蛋白和脂肪酸結(jié)合蛋白在肌鈣蛋白-I增加之前增加，并且肌鈣蛋白-I比肌紅蛋白和脂肪酸結(jié)合蛋白增加的時(shí)間要長。 以下為發(fā)表的文獻(xiàn)： Mouse cTnI Publications Tajiri K, et al.Pitavastatin regulates helper T-cell differentiation and ameliorates autoimmune myocarditis in mice. Cardiovasc Drugs Ther.[Epub ahead of print] (2013) Antoniak S, et al.PAR-1 contributes to the innate immune response during viral infection. J Clin Invest. [Epub ahead of print] (2013)http://www.jci.org/articles/view/66125 Butcher A, et al.An allosteric modulator of the adenosine A1 receptor improves cardiac function following ischaemia in murine isolated hearts. Pharmaceuticals. 6(4):546-556 (2013)http://www.mdpi.com/1424-8247/6/4/546 Taghiabadi E, et al.Protective effect of silymarin against acrolein-induced cardiotoxicity in mice. Evid Based Complement Alternat Med. 352091 (2012)http://www.hindawi.com/journals/ecam/2012/352091/ Foy KC, et al. Immunotherapy with HER-2 and VEGF peptide mimics plus metronomic paclitaxel causes superior antineoplastic effects in transplantable and transgenic mouse models of human breast cancer. OncoImmunology. 1(7):1-13 (2012) http://www.landesbioscience.com/journals/53/article/21057/ Zhang Y, et al. The comparison of α-bromo-4-chlorocinnamaldehyde and cinnamaldehyde on coxsackie virus B3-induced myocarditis and their mechanisms. Int Immunopharmacol. 14(1):107-113 (2012) Bhushan S, et al. Selective β2-Adrenoreceptor Stimulation Attenuates Myocardial Cell Death and Preserves Cardiac Function After Ischemia-Reperfusion Injury. Arterioscler Thromb Vasc Biol. 32(8):1865-1874 (2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401356/ Predmore BL, et al. The polysulfide diallyl trisulfide protects the ischemic myocardium by preservation of endogenous hydrogen sulfide and increasing nitric oxide bioavailability. Am J Physiol Heart Circ Physiol. 302(11):H2410-8 (2012) De Meyer SF, et al. Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice. Blood. [Epub ahead of print] (2012) Peart JN, See Hoe L, Pepe S, Johnson P and Headrick JP. Opposing effects of age and calorie restriction on molecular determinants of myocardial ischemic tolerance. Rejuvenation Res. 15(1):59-70 (2012) Kean TJ, et al. Development of a peptide-targeted, myocardial ischemia-homing, mesenchymal stem cell. J Drug Target. 20(1): 23-32 (2012) Xu Z, Desai M, Philip J, Sivsubramanian N,BowlesNEand Vallejo JG. Conditional transgenic expression of TIR-domain-containing adaptor-inducing interferon-β (TRIF) in the adult mouse heart is protective in acute viral myocarditis. Basic Res Cardiol. 106(6):1159-1171 (2011) Kiraly A, Koffman B, Hacker M, Gunning W, Rasche S, Quinn A. A novel aza-anthrapyrazole blocks the progression of experimental autoimmune encephalomyelitis after the priming of autoimmunity. Clin Immunol. 141(3):304-316 (2011) Ling Y, Pong T, Vassiliou CC, Huang PL and Cima MJ. Implantable magnetic relaxation sensors measure cumulative exposure to cardiac biomarkers. Nat Biotechnol. 29(3):273-277 (2011) Xu B, Strom J and Chen QM. Dexamethasone induces transcriptional activation of Bcl-xL gene and inhibits cardiac injury by myocardial ischemia. Eur J Pharmacol. 668(1-2):194-200 (2011) Braunersreuther V, et al. Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice. J Mol Cell Cardiol. 48(4):789-798 (2010) Haas MS, Alicot EM, Schuerpf F, Chiu I, Li J, Moore FD and Carrol MC. Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction. Cardiovascular Research 87:618-627 (2010) Maas JE, Wan TC, Figler RA, Gross GJ and Auchampach JA. Evidence that the acute phase of ischemic preconditioning does not require signaling by the A 2B adenosine receptor. J Mole Cell Cardiol. 49(5):886-893 (2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958103/ Cao Z, Hu Y, Wu W, Ha T, Kelley J, Deng C, Chen Q, Li J and Li Y. The TIR/BB-loop mimetic AS-1 protects the myocardium from ischemia/reperfusion injury. Cardiovascular Research 84:442-451 (2009) Engle SK, et al. Qualification of cardiac troponin-I concentration in mouse serum using isoproterenol and implementation in pharmacology studies to accelerate drug development. Toxicologic Pathology 37:617-628 (2009) Qi D, Hu X. Wu X, Merk M, Leng L, Bucala R and Young LH. Cardiac Macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion. J Clin Invest. 119:3807-3816 (2009) Richer MJ, Lavallée DJ, Shanina I, Horwitz MS. Toll-Like Receptor 3 Signaling on Macrophages Is Required for Survival Following Coxsackievirus B4 Infection. PLoS ONE 4(1): e4127. doi:10.1371/journal.pone.0004127 (2009) Atkinson C., et al. Complement-dependent inflammation and injury in a murine model of brain dead donor hearts. Circulation Research. 105:1094-1101 (2009) Buyse MG, et al. Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance. Eurpoean Heart Journal 30:116-124 (2009) Elrod JW et.al. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. PNAS 104:15560-15565 (2007) Eckle T, et al. Cardioprotection by Ecto-5′-Nucleotidase (CD73) and A2B Adenosine Receptors. Circulation 115:1581-1590 (2007) Eckle T, et al. Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice. Am J Physiol Heart Circ. Physiol. 291:H2533-H2540 (2006) Hardarson HS, et al. Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury. Am J Physiol Heart Circ. Physiol 292:H251-H258 (2006) Madonna R, Rinaldi L, Rossi C, Geng Y-J and De Caterina R. Prostacyclin improves transcoronary myocardial delivery of adipose tissue-derived stromal cells. Clinical Research 27:2054-2061 (2006) Morrison RR, Tan XL, Ledent C, Mustafa SJ and Hifmann PA. Targeted deletion of A2Aadenosine receptors attenuates the protective effects of myocardial postconditioning. Am J Physiol Heart Circ Physiol. 293:H2523-H2529 (2007) Engle,SKet al. Strain differences in serum cardiac troponin-I concentration and myocardial necrosis after isoproterenol treatment in mice. Abstract No. 383. The Toxicologist CD — An official Journal of the Society of Toxicology, Volume 96, Number S-1 (2007) Hou G, Dick R, Zeng C, Brewer GJ. Comparison of lowering copper levels with tetrathiomolybdate and zinc on mouse tumor and doxorubicin models. Translational Research 148:309-314 (2006) Huber SA, Feldman AM and Sartini D. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-a transgenic mice. Circ Res. 99:1109-1116 (2006) Mullick A, Leon Z, Min-Oo G, Berghout J, Lo R, Daniels E and Gros P. Cardiac failure in C5-deficient mice after Candida albicans infection. Infection and Immunity. 74(8):4439-4451 (2006)Hou G, Dick R, Abrams GD, Brewer GJ., Tetrathiomolybdate protects against cardiac damage by doxorubicin in mice. J Lab Clin Med.146(5):299-303 (2005Tao L, Liu H-R, Gao F, Qu Y, Christopher TA, Lopez BL and Ma XL. Mechanical traumatic injury without circulatory shock causes cardiomyocyte apoptosis: rol of reactive nitrogen and reactive oxygen species. Am J Heart Circ Physiol. 288:H2811-H2818 (2005) Rat cTnI Publications Yeh CH, et al.Potent cardioprotection from ischemia-reperfusion injury by a 2-domain fusion protein comprising Annexin V and Kunitz protease inhibitor.J Thromb Haemost.doi: 10.1111/jth.12314 (2013) Doods H and Wu D.Sabiporide reduces ischemia-induced arrhythmias and myocardial infarction and attenuates ERK phosphorylation and iNOS induction in rats. BioMed Res Int. 2013:504320 (2013)http://www.hindawi.com/journals/bmri/2013/504320/ Ke D, Fang J, Fan L, Chen Z, Chen L.Regulatory T cells contribute to rosuvastatin-induced cardioprotection against ischemia-reperfusion injury.Coron Artery Dis. [Epub ahead of print] (2013) Watts JA, Gellar MA,FulkersonMB, Kline JA.A soluble guanylate cyclase stimulator, BAY 41-8543, preserves right ventricular function in experimental pulmonary embolism.Pulm Pharmacol Ther. [Epub ahead of print] (2012) Cheng K, et al. Magnetic enhancement of cell retention, engraftment and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion. Cell Transplant. 21(6):1121-1135 (2012) http://www.ingentaconnect.com/content/cog/ct/2012/00000021/00000006/art00006 Juneman EB, Saleh L, Lancaster JJ, Thai HM,MarkhamB and Goldman S. The effects of poloxamer-188 on left ventricular function in chronic heart failure after myocardial infarction. J Cardiovasc Pharmacol. 60(3):293-298 (2012) Govindan S, et al. Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction. J Mol Cell Cardiol. 52(1):154-164 (2012) Huang CH, et al. Acute cardiac dysfunction after short-term diesel exhaust particles exposure. Toxicol Lett. 192(3):349-355 (2012) Shin IW, et al. Myocardial protective effect by ulinastatin via an anti-inflammatory response after regional ischemia/reperfusion injury in an in vivo rat heart model. Korean J Anesthesiol. 61(6):499-505 (2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249573/ Li T, et al. Polymerized human placenta hemoglobin given before ischemia protects rat heart from ischemia reperfusion injury. Artif Cells Blood Substit Immobil Biotechnol. 39(6):392-397 (2011) Zisa D, et al. Intramuscular VEGF activates an SDF1-dependent progenitor cell cascade and an SDF1-independent muscle paracrine cascade for cardiac repair. Am J Physiol Heart Circ Physiol. 301(6):H2422-2432 (2011) Shin IW, et al. Propofol has delayed myocardial protective effects after a regional ischemia/reperfusion injury in an in vivo rat heart model. Korean J Anesthesiol. 58(4):378-382 (2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876860/ Todorova VK, Kaufman Y, Hennings LJ and Klimberg VS. Glutamine regulation of doxorubicin accumulation in hearts versus tumors in experimental rats. Cancer Chemother Pharmacol 66:315-323 (2010) Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y and Iwai N. Plasma miR-208 as a Biomarker of Myocardial Injury. Clin Chem. 55(11):1944-1949 (2009) Yue T-L, et.al. In vivo activation of peroxisome proliferator-activated redeptor-d protects the heart from ischemia/reperfusion injury in Zucker fatty rats. J. Pharm. Exp. Ther. 325:466-474 (2008) Zagorski J, Gellar MA, Obraztsova M, Kline JA andWattsJA. Inhibition of CINC-1 decreases right ventricular damage caused by experimental pulmonary embolism in rats. The Journal of Immunology 179:7820-7826 (2007) Legare JF, Oxner A, Heimrath O, Myers T and Currie RW. Heat Shock treatment results in increased recruitment of labeled PMN following myocardial infarction. Am J Physiol Heart Circ Physiol. 293(5):H3210-5 (2007) Chopra M and Sharma AC. Distinct cardiodynamic and molecular chracteristics during early and late stages of sepsis-induced myocardial dysfunction. Life Sciences. epub. July 2007 Liu J, Pang Y, Chang T, Bounelis P,ChathamJC, and Marchase RB. Increased hexoseamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia. J Mol. Cell Cardiol. 40 303-312 (2006) Wang P and Chatham JC. Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart. Am J Physiol Endocrinol Metab 286:E725-E736 (2004) Rabbit cTnI Publications Booth EA, and Lucchesi BR. Medroxyprogesterone acetate prevents the cardioprotective and anti-inflammatory effects of 17beta-estradiol in an in vivo model of myocardial ischemia and reperfusion. Am J Physiol Heart Circ Physiol. 293(3):H1408-15 (2007) Lauver DA, Booth EA, White AJ, Poradosu E & Lucchesi BR. Sulodexide attenuates myocardial ischemia/reperfusion injury and the deposition of C-reactive protein in areas of infarction without affecting hemostasis. J Pharm. Exp. Ther. 312(2):794-800 (2005) Lauver DA, Lockwood SF and Lucchesi BR. Disodium disuccinate astaxanthin (Cardax) attenuates complement activation and reduces myocardial injury following ischemia/reperfusion. J Pharm. Exp. Ther. 314(2):686-692 (2005) Booth EA, Obeid NR and Lucchesi BR. Activation of estrogen receptor-alpha protects the in vivo rabbit heart from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 289(5):H2039-47 (2005) Pig cTnI Publications Uitterdijk A, et al.Serial measurement of hFABP and high sensitivity Troponin I post PCI in STEMI. How fast and accurate can Myocardial Infarct Size and No-Reflow be predictedAm J Physiol Heart Circ Physiol. [Epub ahead of print] (2013) Wu D, Kraut J, and Abraham WM.Sabiporide improves cardiovascular function, decreases the inflammatory response and reduces mortality in acute metabolic acidosis in pigs. PLoS one. 8(1): e53932 (2013)http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0053932 Wu D and Qi J. Mechanisms of the beneficial effect of NHE1 inhibitor in traumatic hemorrhage: inhibition of inflammatory pathways. Resuscitation. 83(6):774-781 (2012) Gill RS, et al. Cyclosporine treatment improves cardiac function and systemic hemodynamics during resuscitation in a newborn piglet model of asphyxia: a dose-response study. Crit Care Med. 40(4): 1237-1244 (2012) Bebarta VS, et al. Hydroxocobalamin and Epinephrine Both Improve Survival in a Swine Model of Cyanide-Induced Cardiac Arrest. Ann Emerg Med. [Epub ahead of print] (2012) Wu D, Qi J, Dai H, Doods H and Abraham WM. Resuscitation with Na+/H+ exchanger inhibitor in traumatic haemorrhagic shock: cardiopulmonary performance, oxygen transport and tissue inflammation. Clin Exp Pharmacol Physiol. 37(3):337-342. (2010) Liu J-Q, Lee T-F, Bigam DL and Cheung P-Y. Effects of post-resuscitation treatment with N-acetylcysteine on cardiac recovery in hypoxic newborn piglets. PLoS one 5(12): e15322 (2010) Osipov RM, et al. Effect of hydrogen sulfide on myocardial protection in the setting of cardioplegia and cardiopulmonary bypass. Interactive CardioVascular and Thoracic Surgery 10: 506-512 (2010) Adams JA, et al. Periodic acceleration (pGz) prior to whole body ischemia reperfusion injury provides early cardioprotective preconditioning. Life Sciences 86: 707-715 (2010) Wu D, Bassuk J, Arias J, Doods H andAdamsJA. Cardiovascular effects of Na+/H+ exchanger inhibition with BIIB513 following hypovolemic circulatory shock. Shock 23(3):269-274 (2005) Monkey cTnI Publications Minimo H, et al. Characteristics of troponins as myocardial damage biomarkers in cynomolgus monkeys. J Toxicol Sci. 34(6): 589-601 (2009) Mouse Myoglobin Publications Nogales-Gadea G, et al. Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease. Brain. 135(Pt 7): 2048-2057 (2012) Ling Y, Pong T, Vassiliou CC, Huang PL, Cima MJ. Implantable magnetic relaxation sensors measure cumulative exposure to cardiac biomarkers. Nat Biotechnol. 29(3):273-277 (2011) Rat Myoglobin Publications Ohta M, Kawano H, Notsu T, Naba H and Imada K. Eicosapentaenoic acid attenuates statin-induced ER stress and toxicity in myoblast. Biochem Biophys Res Commun. 424(2):301-307 (2012) Kerkweg U, Pamp K, Fieker J, Petrat F, Hider RC and de Groot H. Release of redox-active iron by muscle crush trauma: no liberation into the circulation. Shock. 33(5):513-518 (2010) http://journals.lww.com/shockjournal/Fulltext/2010/05000/Release_of_Redox_Active_Iron_By_Muscle_Crush.11.aspx 應(yīng)用聲明：所有產(chǎn)品僅用于科研，不能應(yīng)用于診斷和治療。 其他產(chǎn)品： 急性時(shí)相反應(yīng)純化蛋白和抗體，研究急性炎癥性疾病 研究肝病，肝中毒ELISA試劑盒和純化蛋白 檢測急性時(shí)相反應(yīng)蛋白ELISA試劑盒，研究急性炎癥性疾病 檢測免疫球蛋白ELISA試劑盒 心血管研究用心臟標(biāo)志物抗體 心血管研究用心臟標(biāo)志物純化蛋白 檢測心臟受損標(biāo)志物ELISA試劑盒，用于動(dòng)物心血管研究 骨骼肌受損標(biāo)志物檢測試劑盒 純化的骨骼肌標(biāo)志物 研究生物技術(shù)藥物的免疫毒性ELISA試劑盒 |
回復(fù)此樓» 猜你喜歡
不合理蛙科研實(shí)驗(yàn)中的趣事：實(shí)驗(yàn)器材的 “烏龍”
已經(jīng)有0人回復(fù)
-
不合理蛙科研實(shí)驗(yàn)中的趣事：和實(shí)驗(yàn)材料的 “斗智斗勇”
已經(jīng)有0人回復(fù)
-
化學(xué)工程及工業(yè)化學(xué)論文潤色/翻譯怎么收費(fèi)?
已經(jīng)有55人回復(fù)
-
蛋白質(zhì)檢測：精準(zhǔn)分析，解鎖生物分子的密碼
已經(jīng)有0人回復(fù)
-
不合理蛙科研實(shí)驗(yàn)之小鼠實(shí)驗(yàn)：嚴(yán)謹(jǐn)設(shè)計(jì)，解析生命機(jī)制的重要載體
已經(jīng)有0人回復(fù)
-
不合理蛙科研實(shí)驗(yàn)之重金屬檢測：精準(zhǔn)篩查，守護(hù)健康與環(huán)境的防線
已經(jīng)有0人回復(fù)
-
不合理蛙科研實(shí)驗(yàn)之“蛙測重金屬我背鍋三千”
已經(jīng)有0人回復(fù)
-
不合理蛙科研實(shí)驗(yàn)之“鼠逃三次我發(fā)三篇SCI”
已經(jīng)有0人回復(fù)
-
納米粒度分析
已經(jīng)有3人回復(fù)
-
林科院林化所招收材料與化工專業(yè)碩士，坐標(biāo)南京
已經(jīng)有0人回復(fù)
» 本主題相關(guān)商家推薦: (我也要在這里推廣)
找到一些相關(guān)的精華帖子，希望有用哦~
小鼠ELISA和流式細(xì)胞實(shí)驗(yàn)問題求助
已經(jīng)有8人回復(fù)
- 植物乙酰輔酶A羧化酶(ACC)定量檢測試劑盒（ELISA） 中文說明書
已經(jīng)有13人回復(fù)
- 求助，LPS刺激RAW264.7用ELISA試劑盒檢測TNF-α和IL-6怎么做
已經(jīng)有7人回復(fù)
- ELISA試劑盒使用
已經(jīng)有4人回復(fù)
- 用ELISA試劑盒測炎癥因子的問題
已經(jīng)有6人回復(fù)
- 請問ELISA用的96孔板試劑盒的孔徑多大？
已經(jīng)有4人回復(fù)
- elisa試劑盒檢測免疫因子的相關(guān)問題
已經(jīng)有9人回復(fù)
- 【求助】ELISA 檢測試劑盒里酶標(biāo)準(zhǔn)品稀釋液是什么成分
已經(jīng)有10人回復(fù)
- 【交流】散金幣討論大家Elisa試劑盒都用的哪個(gè)公司的
已經(jīng)有4人回復(fù)
點(diǎn)擊這里搜索更多相關(guān)資源科研從小木蟲開始，人人為我，我為人人
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 seebio66666 的主題更新
| 1 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 333求調(diào)劑 +5 | 87639 2026-03-21 | 7/350 |
|
|---|---|---|---|---|
|
|
[考研]
 一志愿東華大學(xué)控制學(xué)碩320求調(diào)劑
+3
|
Grand777 2026-03-21 | 3/150 |
|
|
|
[考研] 268求調(diào)劑 +9 | 簡單點(diǎn)0 2026-03-17 | 9/450 |
|
|
|
[考研] 279分求調(diào)劑 一志愿211 +14 | chaojifeixia 2026-03-19 | 15/750 |
|
|
|
[考研] 材料專業(yè)求調(diào)劑 +6 | hanamiko 2026-03-18 | 6/300 |
|
|
|
[考研] 274求調(diào)劑 +10 | S.H1 2026-03-18 | 10/500 |
|
|
[考研] 材料專碩英一數(shù)二306 +7 | z1z2z3879 2026-03-18 | 7/350 |
|
|
|
[考研] 295求調(diào)劑 +4 | 一志愿京區(qū)211 2026-03-18 | 6/300 |
|
|
|
[考研] 330求調(diào)劑 +4 | 小材化本科 2026-03-18 | 4/200 |
|
|
|
[考研] 304求調(diào)劑 +7 | 司空. 2026-03-18 | 7/350 |
|
|
|
[考研] 考研調(diào)劑求學(xué)校推薦 +3 | 伯樂29 2026-03-18 | 5/250 |
|
|
|
[考研] 288求調(diào)劑 +16 | 于海海海海 2026-03-19 | 16/800 |
|
|
|
[考研] 0856調(diào)劑，是學(xué)校就去 +8 | sllhht 2026-03-19 | 9/450 |
|
|
|
[考研] 298-一志愿中國農(nóng)業(yè)大學(xué)-求調(diào)劑 +9 | 手機(jī)用戶 2026-03-17 | 9/450 |
|
|
|
[考研] 288求調(diào)劑，一志愿華南理工大學(xué)071005 +5 | ioodiiij 2026-03-17 | 5/250 |
|
|
|
[考研] 材料考研調(diào)劑 +3 | xwt。 2026-03-19 | 3/150 |
|
|
|
[考研] 一志愿985，本科211，0817化學(xué)工程與技術(shù)319求調(diào)劑 +10 | Liwangman 2026-03-15 | 10/500 |
|
|
|
[考研] 085601專碩，總分342求調(diào)劑，地區(qū)不限 +5 | share_joy 2026-03-16 | 5/250 |
|
|
|
[考研] 0854可跨調(diào)劑，一作一項(xiàng)核心論文五項(xiàng)專利，省、國級證書40+數(shù)一英一287 +8 | 小李0854 2026-03-16 | 8/400 |
|
|
|
[考研] 機(jī)械專碩325，尋找調(diào)劑院校 +3 | y9999 2026-03-15 | 5/250 |
|